Explore top UK energy shares for 2025, featuring promising growth strategies and investment cases. Discover insights on leading companies like SAE Renewables and Drax Group...
Los Consejos de Poolbeg Pharma y HOOKIPA Pharma anuncian el respaldo de Gilead para una posible oferta y la actualización de su recaudación de fondos...
Challenger Energy anuncia logros en exploración offshore en 2024, con asociaciones clave y fortalecimiento financiero para impulsar sus proyectos en 2025...
NEXT plc (LON:NXT) boosts profit forecasts as holiday sales surpass expectations, reporting a 10% rise in pre-tax profit and strong future growth guidance...
GSK's ADC GSK5764227 gains FDA Breakthrough Therapy status for treating relapsed or refractory osteosarcoma, addressing critical unmet medical needs...
Poolbeg Pharma and HOOKIPA Pharma confirm Gilead Sciences' support for participation in a $30 million+ private placement fundraise amid potential merger talks...
Explore top UK energy shares for 2025, featuring promising growth strategies and investment cases. Discover insights on leading companies like SAE Renewables and Drax Group...
Los Consejos de Poolbeg Pharma y HOOKIPA Pharma anuncian el respaldo de Gilead para una posible oferta y la actualización de su recaudación de fondos...
Challenger Energy anuncia logros en exploración offshore en 2024, con asociaciones clave y fortalecimiento financiero para impulsar sus proyectos en 2025...
NEXT plc (LON:NXT) boosts profit forecasts as holiday sales surpass expectations, reporting a 10% rise in pre-tax profit and strong future growth guidance...
GSK's ADC GSK5764227 gains FDA Breakthrough Therapy status for treating relapsed or refractory osteosarcoma, addressing critical unmet medical needs...
Poolbeg Pharma and HOOKIPA Pharma confirm Gilead Sciences' support for participation in a $30 million+ private placement fundraise amid potential merger talks...
